{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:19:23Z","timestamp":1790680763188,"version":"4.1.0"},"reference-count":75,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The introduction of high throughput sequencing (HTS) techniques greatly improved the knowledge of inherited thrombocytopenias (ITs) over the last few years. A total of 33 different forms caused by molecular defects affecting at least 32 genes have been identified; along with the discovery of new disease-causing genes, pathogenetic mechanisms of thrombocytopenia have been better elucidated. Although the clinical picture of ITs is heterogeneous, bleeding has been long considered the major clinical problem for patients with IT. Conversely, the current scenario indicates that patients with some of the most common ITs are at risk of developing additional disorders more dangerous than thrombocytopenia itself during life. In particular, MYH9 mutations result in congenital macrothrombocytopenia and predispose to kidney failure, hearing loss, and cataracts, MPL and MECOM mutations cause congenital thrombocytopenia evolving into bone marrow failure, whereas thrombocytopenias caused by RUNX1, ANKRD26, and ETV6 mutations are characterized by predisposition to hematological malignancies. Making a definite diagnosis of these forms is crucial to provide patients with the most appropriate treatment, follow-up, and counseling. In this review, the ITs known to date are discussed, with specific attention focused on clinical presentations and diagnostic criteria for ITs predisposing to additional illnesses. The currently available therapeutic options for the different forms of IT are illustrated.<\/jats:p>","DOI":"10.1182\/asheducation-2017.1.385","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T18:13:11Z","timestamp":1555438391000},"page":"385-399","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":116,"title":["Hereditary thrombocytopenias: a growing list of disorders"],"prefix":"10.1182","volume":"2017","author":[{"given":"Patrizia","family":"Noris","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pecci","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111703192324100_B1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5482\/ha12050001","article-title":"Inherited thrombocytopenias: the evolving spectrum","volume":"32","author":"Balduini","year":"2012","journal-title":"Hamostaseologie"},{"issue":"23","key":"2019111703192324100_B2","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2015-12-688267","article-title":"A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders","volume":"127","author":"Simeoni","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2019111703192324100_B3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ng.884","article-title":"Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome","volume":"43","author":"Kahr","year":"2011","journal-title":"Nat Genet"},{"issue":"16","key":"2019111703192324100_B4","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2014-01-551820","article-title":"A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene","volume":"124","author":"Manchev","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111703192324100_B5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa1308130","article-title":"A dominant-negative GFI1B mutation in the gray platelet syndrome","volume":"370","author":"Monteferrario","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111703192324100_B6","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1073\/pnas.1312520111","article-title":"Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis","volume":"111","author":"Nesin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111703192324100_B7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/jth.12966","article-title":"Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small-platelet thrombocytopenia","volume":"13","author":"Levin","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019111703192324100_B8","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI80347","article-title":"SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects","volume":"125","author":"Fletcher","year":"2015","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111703192324100_B9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"issue":"23","key":"2019111703192324100_B10","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2015-10-675629","article-title":"A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss","volume":"127","author":"Stritt","year":"2016","journal-title":"Blood"},{"issue":"328","key":"2019111703192324100_B11","doi-asserted-by":"crossref","first-page":"328ra30","DOI":"10.1126\/scitranslmed.aad7666","article-title":"A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies","volume":"8","author":"Turro","year":"2016","journal-title":"Sci Transl Med"},{"issue":"6","key":"2019111703192324100_B12","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1182\/blood-2014-03-564328","article-title":"Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111703192324100_B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/09537104.2016.1171835","article-title":"Inherited thrombocytopenias-recent advances in clinical and molecular aspects","volume":"28","author":"Balduini","year":"2017","journal-title":"Platelets"},{"issue":"2","key":"2019111703192324100_B14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/humu.22476","article-title":"MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations","volume":"35","author":"Pecci","year":"2014","journal-title":"Hum Mutat"},{"issue":"1","key":"2019111703192324100_B15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3324\/haematol.2011.050682","article-title":"Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb\u03b1 (Bolzano mutation)","volume":"97","author":"Noris","year":"2012","journal-title":"Haematologica"},{"issue":"24","key":"2019111703192324100_B16","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111703192324100_B17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI86154","article-title":"Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia","volume":"127","author":"Pleines","year":"2017","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111703192324100_B18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/humu.22607","article-title":"Spectrum of the mutations in Bernard-Soulier syndrome","volume":"35","author":"Savoia","year":"2014","journal-title":"Hum Mutat"},{"issue":"3","key":"2019111703192324100_B19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajhg.2013.01.015","article-title":"ACTN1 mutations cause congenital macrothrombocytopenia","volume":"92","author":"Kunishima","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"27","key":"2019111703192324100_B20","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1182\/blood-2009-03-210823","article-title":"Visualizing the von Willebrand factor\/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation","volume":"114","author":"Guerrero","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111703192324100_B21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1055\/s-0031-1291380","article-title":"Glanzmann thrombasthenia-like syndromes associated with macrothrombocytopenias and mutations in the genes encoding the \u03b1IIb\u03b23 integrin","volume":"37","author":"Nurden","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2019111703192324100_B22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1182\/blood-2008-06-162610","article-title":"Mutation of the beta1-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly","volume":"113","author":"Kunishima","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111703192324100_B23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng.103","article-title":"A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia","volume":"40","author":"Morison","year":"2008","journal-title":"Nat Genet"},{"issue":"17","key":"2019111703192324100_B24","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2015-06-650887","article-title":"Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1","volume":"126","author":"Stevenson","year":"2015","journal-title":"Blood"},{"key":"2019111703192324100_B25","article-title":"A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene [published online ahead of print 3 May 2017]","author":"Noris","journal-title":"Br J Haematol"},{"key":"2019111703192324100_B26","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1038\/ncomms11097","article-title":"Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg(2+) homeostasis and cytoskeletal architecture","volume":"7","author":"Stritt","year":"2016","journal-title":"Nat Commun"},{"key":"2019111703192324100_B27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: a comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"16","key":"2019111703192324100_B28","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","article-title":"X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options","volume":"115","author":"Albert","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111703192324100_B29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ajmg.c.31448","article-title":"Jacobsen syndrome: advances in our knowledge of phenotype and genotype","volume":"169","author":"Favier","year":"2015","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"22","key":"2019111703192324100_B30","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1182\/blood-2011-07-365601","article-title":"Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome","volume":"118","author":"Nurden","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111703192324100_B31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0031-1291378","article-title":"Inherited thrombocytopenia due to GATA-1 mutations","volume":"37","author":"Millikan","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"2019111703192324100_B32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1055\/s-0031-1291381","article-title":"Thrombocytopenia-absent radius syndrome","volume":"37","author":"Toriello","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2019111703192324100_B33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ymgme.2014.12.307","article-title":"York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1","volume":"114","author":"Markello","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2019111703192324100_B34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0031-1291377","article-title":"Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment","volume":"37","author":"Ballmaier","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"2019111703192324100_B35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.1083","article-title":"Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome","volume":"44","author":"Albers","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"2019111703192324100_B36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ajhg.2015.10.010","article-title":"Mutations in MECOM, encoding oncoprotein EVI1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia","volume":"97","author":"Niihori","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"10","key":"2019111703192324100_B37","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3324\/haematol.2011.043422","article-title":"Familial myelodysplastic syndromes: a review of the literature","volume":"96","author":"Liew","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"2019111703192324100_B38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2014.10.003","article-title":"Thrombopoiesis","volume":"52","author":"Kaushansky","year":"2015","journal-title":"Semin Hematol"},{"issue":"9","key":"2019111703192324100_B39","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1172\/JCI64721","article-title":"Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling","volume":"123","author":"Hirata","year":"2013","journal-title":"J Clin Invest"},{"key":"2019111703192324100_B40","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1038\/bcj.2015.81","article-title":"Genetic basis of myeloid transformation in familial platelet disorder\/acute myeloid leukemia patients with haploinsufficient RUNX1 allele","volume":"6","author":"Sakurai","year":"2016","journal-title":"Blood Cancer J"},{"issue":"2","key":"2019111703192324100_B41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J Clin Invest"},{"key":"2019111703192324100_B42","author":"Songdej","year":"2017"},{"issue":"2","key":"2019111703192324100_B43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.12752","article-title":"Lessons in platelet production from inherited thrombocytopenias","volume":"165","author":"Pecci","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111703192324100_B44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3324\/haematol.2015.130849","article-title":"Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia","volume":"101","author":"Bury","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"2019111703192324100_B45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bjh.14421","article-title":"Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes","volume":"176","author":"Ong","year":"2017","journal-title":"Br J Haematol"},{"issue":"13","key":"2019111703192324100_B46","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2012-04-422337","article-title":"Dysmegakaryopoiesis of FPD\/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression","volume":"120","author":"Bluteau","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2019111703192324100_B47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.13619","article-title":"Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency","volume":"15","author":"Mao","year":"2017","journal-title":"J Thromb Haemost"},{"key":"2019111703192324100_B48","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ncomms1838","article-title":"Microtubule and cortical forces determine platelet size during vascular platelet production","volume":"3","author":"Thon","year":"2012","journal-title":"Nat Commun"},{"issue":"1","key":"2019111703192324100_B49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/AUD.0000000000000198","article-title":"Nonmuscle myosin heavy chain IIA mutation predicts severity and progression of sensorineural hearing loss in patients with MYH9-related disease","volume":"37","author":"Verver","year":"2016","journal-title":"Ear Hear"},{"issue":"11","key":"2019111703192324100_B50","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3324\/haematol.2016.147496","article-title":"Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia","volume":"101","author":"Melazzini","year":"2016","journal-title":"Haematologica"},{"issue":"20","key":"2019111703192324100_B51","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2019111703192324100_B52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3324\/haematol.2014.105924","article-title":"Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia","volume":"99","author":"Noris","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"2019111703192324100_B53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jth.12196","article-title":"Inherited thrombocytopenias frequently diagnosed in adults","volume":"11","author":"Balduini","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111703192324100_B54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cge.12603","article-title":"Diagnosis and treatment of inherited thrombocytopenias","volume":"89","author":"Pecci","year":"2016","journal-title":"Clin Genet"},{"issue":"10","key":"2019111703192324100_B55","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2016.146316","article-title":"Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects","volume":"101","author":"Johnson","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"2019111703192324100_B56","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/ndt\/gfn277","article-title":"Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)","volume":"23","author":"Pecci","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2019111703192324100_B57","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1002\/ajh.24703","article-title":"Mutations of RUNX1 in families with inherited thrombocytopenia","volume":"92","author":"De Rocco","year":"2017","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111703192324100_B58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","article-title":"A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO","volume":"135","author":"Bolton-Maggs","year":"2006","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111703192324100_B59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111703192324100_B60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"2019111703192324100_B61","article-title":"European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","author":"Orsini"},{"issue":"26","key":"2019111703192324100_B62","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2010-08-304725","article-title":"Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations","volume":"116","author":"Pecci","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111703192324100_B63","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1160\/TH12-01-0005","article-title":"Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation","volume":"107","author":"Pecci","year":"2012","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111703192324100_B64","doi-asserted-by":"crossref","first-page":"e793","DOI":"10.1542\/peds.2012-3807","article-title":"First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia","volume":"132","author":"Favier","year":"2013","journal-title":"Pediatrics"},{"issue":"8","key":"2019111703192324100_B65","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1080\/09537104.2016.1190446","article-title":"Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia","volume":"27","author":"Fiore","year":"2016","journal-title":"Platelets"},{"issue":"11","key":"2019111703192324100_B66","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-09-602573","article-title":"Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome\/X-linked thrombocytopenia","volume":"126","author":"Gerrits","year":"2015","journal-title":"Blood"},{"issue":"15","key":"2019111703192324100_B67","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"2019111703192324100_B68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10875-014-0105-5","article-title":"Hematopoietic stem cell transplantation for X-Linked thrombocytopenia with mutations in the WAS gene","volume":"35","author":"Oshima","year":"2015","journal-title":"J Clin Immunol"},{"issue":"1","key":"2019111703192324100_B69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0037-1612582","article-title":"Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome","volume":"95","author":"Rieger","year":"2006","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111703192324100_B70","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111703192324100_B71","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bmt.2012.31","article-title":"Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome","volume":"47","author":"Shin","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111703192324100_B72","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.bbmt.2013.12.099","article-title":"Allogeneic stem cell transplantation in amegacaryocytosis: results of a retrospective study in EBMT centers","volume":"20","author":"Dalle","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"227","key":"2019111703192324100_B73","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci Transl Med"},{"issue":"6148","key":"2019111703192324100_B74","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"issue":"10","key":"2019111703192324100_B75","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1172\/JCI82249","article-title":"Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients","volume":"125","author":"Pala","year":"2015","journal-title":"J Clin Invest"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/385\/1251478\/hem00054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/385\/1251478\/hem00054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T03:20:06Z","timestamp":1573960806000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2017\/1\/385\/21213\/Hereditary-thrombocytopenias-a-growing-list-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2017.1.385","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}